Rates, Predictors, and Outcomes of Early and Late Recurrence After Stroke

Author:

Callaly Elizabeth1,Ni Chroinin Danielle1,Hannon Niamh1,Marnane Michael1,Akijian Layan1,Sheehan Orla1,Merwick Aine1,Hayden Derek1,Horgan Gillian1,Duggan Joseph1,Murphy Sean1,O’Rourke Killian1,Dolan Eamon1,Williams David1,Kyne Lorraine1,Kelly Peter J.1

Affiliation:

1. From the Neurovascular Unit for Applied Research, Mater University Hospital, University College Dublin, Dublin, Ireland (E.C., D.N.C., N.H., M.M., L.A., O.S., A.M., D.H., G.H., J.D., S.M., K.O’R., L.K., P.J.K.); Departments of Geriatric and Stroke Medicine, Connolly Hospital, Dublin, Ireland (E.D.); Beaumont Hospital, Dublin, Ireland (D.W.); and Royal College of Surgeons, Dublin, Ireland (S.M., D.W.).

Abstract

Background and Purpose— Few recent studies have investigated the rates and predictors of early and late stroke recurrence using prospective population–based methodology. We investigated recurrent stroke at 2 years in the North Dublin Population Stroke Study (NDPSS). Methods— Patients were ascertained from December 2005 to 2006 from overlapping community and hospital sources using hot and cold pursuit. Stroke recurrence, survival, and functional outcome were ascertained at 72 hours, 7 days, 28 days, 90 days, 1 year, and 2 years. Results— Of 567 patients, cumulative 2-year stroke recurrence rate was 10.8% and case fatality was 38.6%. Recurrence subtype was associated with initial stroke subtype ( P <0.001). On multivariable Cox regression, hyperlipidemia (adjusted hazard ratio, 3.32; P =0.005) and prior stroke (adjusted hazard ratio, 2.92; P =0.01) were independent predictors of 2-year recurrence in 28-day survivors. Conclusions— Despite rigorous ascertainment, recurrent stroke rates were lower in current study than in earlier studies. Our data suggest that large sample sizes may be needed for future secondary prevention trials in patients treated with modern preventive medications.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3